GILD vs ABBV
Gilead Sciences vs AbbVie — AI-powered side-by-side comparison
| Metric | GILD | ABBV |
|---|---|---|
| AI Score | 66 | 54 |
| Price | $129.81 | $247.97 |
| P/E Ratio | 18.11× | 121.64× |
| ROE | 42.2% | -1.3% |
| Revenue Growth YoY | 3.5% | — |
| Gross Margin | 79.3% | 0.7% |
| Debt / Equity | 1.10× | 2.65× |
| Dividend Yield | 2.4% | 0.0% |
| RSI (14) | 49.2 | 53.2 |
| Beta | 0.3411 | 0.283 |
| Expected Upside | +21.1% | — |
Want the full breakdown?
Committee votes, technicals, and trade plans for both companies.
GILD Full Analysis
ABBV Full Analysis